Conjugates of GM-CSF and IL-7, and Compositions Thereof
AssigneesEmory University, Children's Healthcare of Atlanta, Inc.
InventorsJacques Galipeau, Hsiang-Chuan Hsieh
Life of this patent
Estimating the term…
Abstract
In certain embodiments, this disclosure relates to conjugates comprising GM-CSF and IL-7 and uses related thereto, e.g., enhancing the adaptive immune system. Typically the GM-CSF and IL-7 are connected by a polymer linker, e.g., polypeptide. In certain embodiments, the disclosure relates to nucleic acids encoding these polypeptide conjugates, vectors comprising nucleic acid encoding polypeptide conjugates, and protein expression systems comprising these vectors such as infectious viral particles and host cells comprising such a nucleic acids.
Claims5
A method of enhancing an immune response comprising administering a conjugate comprising a GM-CSF polypeptide and an IL-7 polypeptide having SEQ ID NO:
- 1 to a subject in need thereof.
The method of claim 2, further comprising administering an antigen to the subject.
A method of treating or preventing a viral infection comprising administering an effective amount of a pharmaceutical composition comprising a conjugate comprising a GM-CSF polypeptide and an IL-7 polypeptide having SEQ ID NO:
- 1 to a subject in need thereof, optionally in combination with an antigen and an adjuvant.
A method of treating or preventing a viral infection in a subject in need thereof comprising administering an effective amount of a vaccine in combination with a conjugate comprising a GM-CSF polypeptide and an IL-7 polypeptide having SEQ ID NO:
- 1 to the subject.
Dependencies are inferred from the claim text.